These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32799675)

  • 1. Early antihypertensive treatment and ischemia-induced acute kidney injury.
    Greite R; Derlin K; Hensen B; Thorenz A; Rong S; Chen R; Hellms S; Jang MS; Bräsen JH; Meier M; Willenberg I; Immenschuh S; Haller H; Luft FC; Panigrahy D; Hwang SH; Hammock BD; Schebb NH; Gueler F
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F563-F570. PubMed ID: 32799675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
    Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
    Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
    Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
    Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.
    Bukhari IA; Mohamed OY; Mahmood A; Alfadda AA; Almotrefi AA
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(10):3835-3847. PubMed ID: 34109592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.
    Ulu A; Stephen Lee KS; Miyabe C; Yang J; Hammock BG; Dong H; Hammock BD
    J Cardiovasc Pharmacol; 2014 Jul; 64(1):87-99. PubMed ID: 24691274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
    Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
    ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
    Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
    Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
    Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
    Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains.
    Tewes S; Gueler F; Chen R; Gutberlet M; Jang MS; Meier M; Mengel M; Hartung D; Wacker F; Rong S; Hueper K
    PLoS One; 2017; 12(3):e0173248. PubMed ID: 28319118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.
    Sharkovska Y; Kalk P; von Websky K; Relle K; Pfab T; Alter M; Fischer Y; Hocher B
    Clin Lab; 2011; 57(7-8):507-15. PubMed ID: 21888014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
    Honetschlägerová Z; Husková Z; Vaňourková Z; Sporková A; Kramer HJ; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Červenka L; Kopkan L
    J Physiol; 2011 Jan; 589(Pt 1):207-19. PubMed ID: 21078594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
    Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
    Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction.
    Guo Y; Luo F; Zhang X; Chen J; Shen L; Zhu Y; Xu D
    J Cell Mol Med; 2018 Mar; 22(3):1489-1500. PubMed ID: 29265525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
    Kakoki M; Hirata Y; Hayakawa H; Suzuki E; Nagata D; Nishimatsu H; Kimura K; Goto A; Omata M
    Hypertens Res; 2000 Sep; 23(5):527-33. PubMed ID: 11016809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.